LOINC
Version 2.68

10709-4Plasmodium falciparum Ag [Units/volume] in Blood by ImmunofluorescenceActive

Part Descriptions

LP14839-2   Plasmodium falciparum
Four species of the Plasmodium protozoa are considered true parasites of humans as they use humans almost exclusively as a natural intermediate host: P. falciparum, P. vivax, P. ovale and P. malariae. Malaria today is usually restricted to tropical and subtropical areas and altitudes below 1,500 m., although in the past malaria was endemic in much of North America, Europe and even parts of northern Asia, and today is still present on the Korean peninsula. However, this present distribution could be affected by climatic changes and population movements. P. falciparum is the most prevalent species and responsible for the most morbidity and mortality worldwide. Early detect is of paramount importance due to the incidence of cerebral malaria and drug resistance. Malarial infections caused by P. falciparum are the most likely to progress to severe, potentially fatal forms with central nervous system involvement (cerebral malaria), acute renal failure, severe anemia, or acute respiratory distress syndrome.[CDC] Source: Regenstrief LOINC, CDC

LP20149-8   Plasmodium
Malaria is a parasitic disease that is passed from one human to another by the bite of an infected Anopheles mosquito with one of four protozoan parasites: Plasmodium falciparum, vivax, malariae or ovale. The parasites enter the bloodstream and infect red blood cells where they multiply and infect more red blood cells. Symptoms usually occur 10 days to 4 weeks after infection and include anemia, high fevers, shaking chills, muscle pain, and nausea. Antimalarial agents used to treat malaria include Quinine, Quinidine, Mefloquine, Chloroquine, and Hydroxychloroquine. The effectiveness of the agents depends on which phase or phases of the Plasmodium life cycle is interrupted. In most cases, treatment outcome is expected to be good except in cases of a p. falciparum infection. Adverse effects from antimalaria medications include vomiting, diarrhea, headaches, cardiac arrhythmias, EKG abnormalities, deafness, damage to liver and kidney and muscle weakness. Source: NMS labs

Fully-Specified Name

Component
Plasmodium falciparum Ag
Property
ACnc
Time
Pt
System
Bld
Scale
Qn
Method
IF

Additional Names

Short Name
P falciparum Ag Bld IF-aCnc
Display Name
P. falciparum Ag IF Qn (Bld)

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 1.0i
Last Updated
Version 2.21
Order vs. Observation
Both

Member of these Groups

LG41640-0 Plasmodium

Language Variants Get Info

zh-CNChinese (CHINA)
恶性疟原虫 抗原:任意型浓度:时间点:全血:定量型:免疫荧光法
nl-NLDutch (NETHERLANDS)
Plasmodium falciparum Ag:eenheid/volume:moment:bloed:kwantitatief:immunofluorescentie
et-EEEstonian (ESTONIA)
Plasmodium falciparum antigeen:Acnc:Pt:B:Qn:IF
fr-BEFrench (BELGIUM)
Plasmodium falciparum Ag:Concentration arbitraire:Temps ponctuel:Sang:Quantitatif:Immunofluorescence
fr-CAFrench (CANADA)
Plasmodium falciparum , Ag:Concentration arbitraire:Temps ponctuel:Sang:Quantitatif:Immunofluorescence
fr-FRFrench (FRANCE)
Plasmodium falciparum Ag:Arbitraire/Volume:Ponctuel:Sang:Numérique:Immunofluorescence
de-DEGerman (GERMANY)
Plasmodium falciparum Ag:AKnz:Pkt:Blut:Qn:IF
it-ITItalian (ITALY)
Plasmodium falciparum , Ag:ACnc:Pt:Sangue:Qn:IF
ko-KRKorean (KOREA, REPUBLIC OF)
열대열원충 항원:임의농도:검사시점:전혈:정량:면역형광
pt-BRPortuguese (BRAZIL)
Plasmodium falciparum Ag:ACnc:Pt:SgTotal:Qn:Imunofluorescência
ru-RURussian (RUSSIAN FEDERATION)
Plasmodium falciparum Аг:ПроизвКонц:ТчкВрм:Кр:Колич:ИФ
es-ARSpanish (ARGENTINA)
antígeno del Plasmodium falciparum:concentración arbitraria:punto en el tiempo:sangre:cuantitativo:inmunofluorescencia
es-ESSpanish (SPAIN)
Plasmodium falciparum Antígeno:Concentración arbitraria:Punto temporal:Sangre:Qn:Inmunofluorescencia (IF)
tr-TRTurkish (TURKEY)
Plasmodium falciparum Ag:SçKons:Zmlı:Kan:Kant:IF

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=10709-4